AbbVie M21-446: A single arm open-label study to evaluate the efficacy and safety of ABBV-668 in Subjects with Moderate to Severe Ulcerative Colitis

Brief description of study

AbbVie M21-446: A single arm, open-label study to evaluate the efficacy and safety of ABBV-668 in Subjects with Moderate to Severe Ulcerative Colitis


Clinical Study Identifier: s22-01178
ClinicalTrials.gov Identifier: NCT05570006
Principal Investigator: Lev Ginzburg.


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.